These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9606809

  • 21. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 22. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
    Yamazaki K, Masugi Y, Sakamoto M.
    Dig Dis; 2011 May 15; 29(3):284-8. PubMed ID: 21829019
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. TGF-β signaling in onset and progression of hepatocellular carcinoma.
    Meindl-Beinker NM, Matsuzaki K, Dooley S.
    Dig Dis; 2012 May 15; 30(5):514-23. PubMed ID: 23108308
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH.
    Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326
    [Abstract] [Full Text] [Related]

  • 30. Integration of Ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis.
    Fischer AN, Herrera B, Mikula M, Proell V, Fuchs E, Gotzmann J, Schulte-Hermann R, Beug H, Mikulits W.
    Carcinogenesis; 2005 May 15; 26(5):931-42. PubMed ID: 15705598
    [Abstract] [Full Text] [Related]

  • 31. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma.
    Gold LI, Parekh TV.
    Semin Reprod Endocrinol; 1999 May 15; 17(1):73-92. PubMed ID: 10406078
    [Abstract] [Full Text] [Related]

  • 32. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
    Lu Y, Wu LQ, Li CS, Wang SG, Han B.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 15; 7(2):174-8. PubMed ID: 18397854
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME, Datta PK, Moses HL.
    J Cell Biochem Suppl; 1998 Mar 29; 30-31():111-22. PubMed ID: 9893262
    [Abstract] [Full Text] [Related]

  • 40. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI.
    Crit Rev Oncog; 1999 Mar 29; 10(4):303-60. PubMed ID: 10654929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.